Warby Parker
WRBY
$27.46
-3.65%
Warby Parker Inc. is a mission-driven, lifestyle brand operating at the intersection of design, technology, healthcare, and social enterprise, offering eyewear, contacts, and eye care directly to consumers through its integrated omnichannel platform. As a disruptor in the optical industry, it has redefined the traditional eyewear market with its direct-to-consumer model and social good initiatives, positioning itself as a niche leader in affordable, stylish vision care. The current investor narrative centers on the company's growth trajectory, profitability inflection, and expansion of its retail footprint, while also debating the sustainability of its valuation and competitive moat in a post-pandemic environment. Recent attention has been on its improving margins and the potential for continued market share gains, though the stock has experienced volatility amid broader market swings.…
WRBY
Warby Parker
$27.46
WRBY 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Warby Parker's 12-month outlook, with a consensus price target around $30.46 and implied upside of +10.9% versus the current price.
Average Target
$30.46
0 analysts
Implied Upside
+10.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$24 - $35
Analyst target range
Warby Parker is covered by 13 analysts, with a consensus recommendation of 'buy' and a mean rating of 1.71 (where 1 is strong buy and 5 is sell). The average target price is $30.46, implying an upside of approximately 17.6% from the current price of $25.91. The target range spans from $24.00 to $35.00, with the low end suggesting a potential downside of 7.4% and the high end implying a 35.1% upside. The wide spread indicates significant uncertainty about the company's future performance, but the overall bullish sentiment suggests analysts see more upside than downside.
Bulls vs Bears: WRBY Investment Factors
Warby Parker presents a mixed picture: strong revenue growth and improving margins are countered by an extremely high trailing valuation and negative operating margin. The bull case is supported by analyst optimism and forward EPS acceleration, while the bear case highlights the stock's volatility and underperformance. Currently, the evidence slightly favors the bulls given the consensus buy rating and upside to targets, but the key tension is whether the company can achieve the expected earnings growth to justify its valuation. If growth decelerates or margins fail to improve, the stock could face significant downside.
Bullish
- Strong Revenue Growth: Latest quarterly revenue is estimated at $1.56 billion (annualized), reflecting robust growth. This indicates strong consumer demand and successful expansion of the omnichannel model.
- Healthy Gross Margin: Gross margin stands at 54.0%, demonstrating strong pricing power and efficient cost management. This provides a solid foundation for future profitability.
- Analyst Consensus Buy: With 13 analysts, the consensus recommendation is 'buy' with a mean rating of 1.71 (1=strong buy, 5=sell). The average target price of $30.46 implies a 17.6% upside from the current price of $25.91.
- Positive Net Margin Milestone: Net margin has turned positive at 0.19%, a significant milestone for the company. This indicates that the company is moving towards sustainable profitability.
Bearish
- Extremely High Trailing PE: The trailing PE ratio is 1,626x, reflecting minimal current earnings. This makes the stock highly sensitive to any earnings disappointment.
- Negative Operating Margin: Operating margin is -0.6%, indicating the company is still investing heavily in growth. This could pressure cash flows and delay profitability.
- Underperformance vs. Market: Over the past year, WRBY has declined 3.5% while the S&P 500 gained 20.4%. This relative weakness suggests investor skepticism and potential momentum issues.
- High Beta and Volatility: With a beta of 1.93, the stock is highly sensitive to market swings. This increases downside risk in a market downturn, as seen in the 42.26% max drawdown.
WRBY Technical Analysis
Warby Parker's stock is currently in a recovery phase, having rebounded significantly from its 52-week low of $14.96, but it remains below its 52-week high of $31.00. Over the past year, the stock has declined 3.5%, underperforming the S&P 500's 20.4% gain, indicating relative weakness. The current price of $25.91 sits at approximately 83.6% of the 52-week range, suggesting it is closer to the highs but with room to run, which could imply either momentum or potential overextension.
Beta
1.93
1.93x market volatility
Max Drawdown
-42.3%
Largest decline past year
52-Week Range
$15-$31
Price range past year
Annual Return
+3.4%
Cumulative gain past year
| Period | WRBY Return | S&P 500 |
|---|---|---|
| 1m | +11.6% | +1.9% |
| 3m | +9.4% | +2.3% |
| 6m | +15.8% | +10.6% |
| 1y | +3.4% | +19.5% |
| ytd | +21.4% | +11.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
WRBY Fundamental Analysis
Warby Parker's revenue growth has been robust, with the latest quarterly revenue estimated at $1.56 billion (annualized), reflecting a strong trajectory. The company's gross margin stands at 54.0%, indicating healthy pricing power and cost management. However, the operating margin is slightly negative at -0.6%, showing that the company is still investing heavily in growth, though net margin has turned positive at 0.19%, a significant milestone. The company's EPS is $0.0006, barely profitable, but forward EPS estimates of $0.99 suggest a sharp acceleration in profitability expected by analysts.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is WRBY Overvalued?
Given that Warby Parker's trailing net income is positive (EPS of $0.0006), the PE ratio is the primary valuation metric, but it is extremely high at 1,626x trailing, reflecting minimal current earnings. The forward PE of 42.5x is more reasonable and implies the market expects substantial earnings growth, as evidenced by the estimated EPS of $0.99 for the next fiscal year. The PEG ratio is negative (-15.1) due to negative earnings growth expectations, which is a red flag, but this may be a data artifact.
PE
1626.1x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
49.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant. The company has a debt-to-equity ratio of 0.63, indicating moderate leverage. While the current ratio of 2.35 suggests adequate liquidity, the negative operating margin of -0.6% implies ongoing cash burn. Revenue concentration in eyewear products and services could be a risk if consumer spending shifts. The extremely high trailing PE of 1,626x leaves no room for error; any earnings miss could trigger a sharp sell-off. Additionally, the company's reliance on continued growth to justify its valuation is a key vulnerability.
Market and competitive risks are also notable. The stock trades at a premium valuation with a forward PE of 42.5x and PS of 3.07x, which could compress if growth slows. The high beta of 1.93 makes it susceptible to market downturns, and the stock has underperformed the market over the past year. Competitive pressures from other DTC eyewear brands and traditional retailers could erode market share. Regulatory changes in healthcare or e-commerce could also pose risks. The short interest ratio of 7.25 indicates some bearish sentiment.
In a worst-case scenario, if the company fails to achieve profitability and growth stalls, the stock could decline to its 52-week low of $14.96, representing a -42.3% loss from the current price of $25.91. This would be exacerbated by the high beta and negative market sentiment. The max drawdown of -42.26% already demonstrates the potential for significant losses. Investors should be prepared for high volatility and the possibility of substantial downside.